Canadian psychedelic stock PharmAla Biotech (CSE:MDMA) is up after signing a contract to supply MDMA for a clinical trial at Yale University.
Vous n'êtes pas connecté
PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital.
Canadian psychedelic stock PharmAla Biotech (CSE:MDMA) is up after signing a contract to supply MDMA for a clinical trial at Yale University.
Celebrate Harvard’s Annual Arts First Festival, a vibrant showcase of campus entertainment, featuring student performances across music, dance,...
Comedy has long been a part of student life at Harvard University, with The Harvard Lampoon leading the way in campus humor. Known for its unique...
Harvard University’s annual blood drives have become a powerful force for life-saving charity, uniting students, staff, and community members to...
Explore how Harvard University supports charity through sports, with fundraising events that combine athletics and philanthropy to make a positive...
Competitive: Medpace: Medpace is the leading CRO for Biotech companies and is continuing to add established Clinical Trial Managers and Project...
Competitive: Medpace: Medpace is the leading CRO for Biotech companies and is continuing to add established Clinical Trial Managers and Project...
Competitive: Medpace: Medpace is the leading CRO for Biotech companies and is continuing to add established Clinical Trial Managers and Project...
Kenya Medical Research Institute (KEMRI), the country's premier research institution, said Wednesday that it has signed a partnership deal with Tonix...
Encouraging findings with immunotherapy aiming at ART-free virological control A significant step towards functional cure of HIV infection HONG KONG...